Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Implementing the National Academy's Vision and Strategy for Toxicity Testing: opportunities and challenges under the U.S. Toxic Substances Control Act.

Locke PA, Bruce Myers D Jr.

J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):376-84. doi: 10.1080/10937404.2010.483952.

PMID:
20574909
2.

The future of toxicity testing.

Andersen ME, Al-Zoughool M, Croteau M, Westphal M, Krewski D.

J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):163-96. doi: 10.1080/10937404.2010.483933. Review.

PMID:
20574896
3.

Toxicity testing in the 21st century: bringing the vision to life.

Andersen ME, Krewski D.

Toxicol Sci. 2009 Feb;107(2):324-30. doi: 10.1093/toxsci/kfn255. Epub 2008 Dec 12. Review.

PMID:
19074763
4.

Exposure science and the U.S. EPA National Center for Computational Toxicology.

Cohen Hubal EA, Richard AM, Shah I, Gallagher J, Kavlock R, Blancato J, Edwards SW.

J Expo Sci Environ Epidemiol. 2010 May;20(3):231-6. doi: 10.1038/jes.2008.70. Epub 2008 Nov 5. Review.

PMID:
18985077
5.

New directions in toxicity testing.

Krewski D, Westphal M, Al-Zoughool M, Croteau MC, Andersen ME.

Annu Rev Public Health. 2011;32:161-78. doi: 10.1146/annurev-publhealth-031210-101153. Review.

PMID:
21219154
6.

Uncertainties for endocrine disrupters: our view on progress.

Daston GP, Cook JC, Kavlock RJ.

Toxicol Sci. 2003 Aug;74(2):245-52. Epub 2003 May 2. Review.

PMID:
12730617
9.

The U.S. Environmental Protection Agency's risk assessment guidelines.

Jarabek AM, Farland WH.

Toxicol Ind Health. 1990 Oct;6(5):199-216. Review.

PMID:
2274984
10.

EPA's neurotoxicity risk assessment guidelines.

Boyes WK, Dourson ML, Patterson J, Tilson HA, Sette WF, MacPhail RC, Li AA, O'Donoghue JL.

Fundam Appl Toxicol. 1997 Dec;40(2):175-84. Review.

PMID:
9441713
11.

The legal failure to prevent subclinical developmental toxicity.

Cranor C.

Basic Clin Pharmacol Toxicol. 2008 Feb;102(2):267-73. doi: 10.1111/j.1742-7843.2007.00170.x. Review.

12.

The U.S. EPA Science Advisory Board Evaluation (2001) of the EPA dioxin reassessment.

Paustenbach DJ; EPA Science Advisory Board.

Regul Toxicol Pharmacol. 2002 Oct;36(2):211-9. Review.

PMID:
12460755
13.

U.S. EPA regulatory perspectives on the use of QSAR for new and existing chemical evaluations.

Zeeman M, Auer CM, Clements RG, Nabholz JV, Boethling RS.

SAR QSAR Environ Res. 1995;3(3):179-201. Review.

PMID:
8564854
14.
15.

Air toxics in the U.S.: magnitude of the problem and strategy for control.

Berry DK.

Toxicol Ind Health. 1990 Oct;6(5):1-12. Review.

PMID:
2274973
16.

Risk management frameworks for human health and environmental risks.

Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.

J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.

PMID:
14698953
17.

The vision of toxicity testing in the 21st century: moving from discussion to action.

Andersen ME, Krewski D.

Toxicol Sci. 2010 Sep;117(1):17-24. doi: 10.1093/toxsci/kfq188. Epub 2010 Jun 23. Review.

PMID:
20573784
18.

Toxicity testing in the 21st century: a vision and a strategy.

Gibb S.

Reprod Toxicol. 2008 Jan;25(1):136-8. Epub 2007 Nov 1. Review.

PMID:
18093799
19.

Implications of chemical mixtures in public health practice.

de Rosa CT, El-Masri HA, Pohl H, Cibulas W, Mumtaz MM.

J Toxicol Environ Health B Crit Rev. 2004 Sep-Oct;7(5):339-50. Review.

PMID:
15371239
20.

Supplemental Content

Support Center